Cases Investigated

Beasley Allen is currently investigating cases involving securities and investments fraud. However, our attorneys would like to investigate any claims of loss in any industry that may be the result of fraud.

Merck to pay $830 million to settle investors’ Vioxx fraud claims

January 15, 2016 - Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing securities fraud by illegally promoting its anti-inflammatory drug Vioxx for... Read More

back to top